Detalhe da pesquisa
1.
Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan.
Jpn J Clin Oncol
; 49(8): 766-771, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31329922